Clinical Trials Directory

Trials / Unknown

UnknownNCT01748903

TARGET Intracranial Aneurysm Coiling Registry

TARGET Intracranial Aneurysm Coiling Registry: A Prospective Clinical Efficacy and Safety Study of Stryker Target® 360°, Target® Helical, and 2nd Generation Target® Nano Coils

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Mercy Health Ohio · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.

Conditions

Interventions

TypeNameDescription
DEVICETarget 360°, 2D Coils, Nano Coils

Timeline

Start date
2013-02-01
Primary completion
2019-01-01
Completion
2019-03-01
First posted
2012-12-13
Last updated
2018-07-24

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01748903. Inclusion in this directory is not an endorsement.

TARGET Intracranial Aneurysm Coiling Registry (NCT01748903) · Clinical Trials Directory